Jessica L Dunne
Overview
Explore the profile of Jessica L Dunne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
910
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kelly C, Wolf W, Cornelius E, Peter M, Chapman K, Dunne J
Diabetes Ther
. 2024 Aug;
15(10):2249-2261.
PMID: 39190273
Introduction: Screening for islet-specific autoantibodies can identify individuals at risk for type 1 diabetes (T1D). Despite calls for increased nationwide autoantibody screening efforts, it is unclear how many individuals have...
2.
Ghalwash M, Anand V, Ng K, Dunne J, Lou O, Lundgren M, et al.
Diabetes Care
. 2024 Jun;
47(8):1424-1431.
PMID: 38861550
Objective: To characterize distinct islet autoantibody profiles preceding stage 3 type 1 diabetes. Research Design And Methods: The T1DI (Type 1 Diabetes Intelligence) study combined data from 1,845 genetically susceptible...
3.
Frohnert B, Ghalwash M, Li Y, Ng K, Dunne J, Lundgren M, et al.
Diabetes Care
. 2023 Mar;
46(10):1753-1761.
PMID: 36862942
Objective: To estimate the risk of progression to stage 3 type 1 diabetes based on varying definitions of multiple islet autoantibody positivity (mIA). Research Design And Methods: Type 1 Diabetes...
4.
Wilson D, Pietropaolo S, Acevedo-Calado M, Huang S, Anyaiwe D, Scheinker D, et al.
Diabetes Care
. 2023 Feb;
46(3):526-534.
PMID: 36730530
Objective: Continuous glucose monitoring (CGM) parameters may identify individuals at risk for progression to overt type 1 diabetes. We aimed to determine whether CGM metrics provide additional insights into progression...
5.
Karpen S, Dunne J, Frohnert B, Marinac M, Richard C, David S, et al.
Diabetologia
. 2022 Jul;
66(3):415-424.
PMID: 35867129
The development of medical products that can delay or prevent progression to stage 3 type 1 diabetes faces many challenges. Of note, optimising patient selection for type 1 diabetes prevention...
6.
Ghalwash M, Dunne J, Lundgren M, Rewers M, Ziegler A, Anand V, et al.
Lancet Diabetes Endocrinol
. 2022 Jul;
10(8):589-596.
PMID: 35803296
Background: Early prediction of childhood type 1 diabetes reduces ketoacidosis at diagnosis and provides opportunities for disease prevention. However, only highly efficient approaches are likely to succeed in public health...
7.
Dunne J, Maizel J, Posgai A, Atkinson M, DiMeglio L
Diabetes Care
. 2022 May;
45(5):e99.
PMID: 35561137
No abstract available.
8.
Dunne J, Maizel J, Posgai A, Atkinson M, DiMeglio L
Diabetes
. 2022 Apr;
70(8):1623-1633.
PMID: 35381061
Women are broadly underrepresented in scientific leadership positions and their accomplishments are not provided equal recognition compared with those of men, but the imbalance in the field of diabetes is...
9.
Dunne J, Maizel J, Posgai A, Atkinson M, DiMeglio L
Diabetes
. 2022 Apr;
71(6):1371.
PMID: 35380651
No abstract available.
10.
Dunne J, Maizel J, Posgai A, Atkinson M, DiMeglio L
Diabetes Care
. 2022 Apr;
45(6):1491.
PMID: 35380617
No abstract available.